Showing results (151-160 of 185) with videos related to
Sort By:
Pageof 19
Trials|September 10, 2013
Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trialKerry-Ann F O'Grady, Keith Grimwood, Allan Cripps, et al.Archives of Disease in Childhood|April 13, 2018
Research priority setting in childhood chronic disease: a systematic reviewHarrison Lindsay Odgers, Allison Tong, Pamela Lopez-Vargas, et al.Vaccine|January 9, 2023
A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)Robert Lupinacci, Richard Rupp, Orasri Wittawatmongkol, et al.Pediatrics|June 13, 2023
Safety and Tolerability of V114 Pneumococcal Vaccine in Infants: A Phase 3 StudyNatalie Banniettis, Michael Horn, Manish Sadarangani, et al.BMJ Open|July 12, 2018
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescentsHelen S Marshall, Mark McMillan, Ann Koehler, et al.Vaccine|December 3, 2014
Febrile seizures following measles and varicella vaccines in young children in AustraliaKristine K Macartney, Heather F Gidding, Lieu Trinh, et al.Frontiers in Immunology|November 9, 2020
Corrigendum: Pediatric Burn Survivors Have Long-Term Immune Dysfunction With Diminished Vaccine ResponseBlair Z Johnson, Sonia McAlister, Helen M McGuire, et al.Frontiers in Immunology|August 15, 2020
Pediatric Burn Survivors Have Long-Term Immune Dysfunction With Diminished Vaccine ResponseBlair Z Johnson, Sonia McAlister, Helen M McGuire, et al.The New England Journal of Medicine|January 24, 2020
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in AustraliaHelen S Marshall, Mark McMillan, Ann P Koehler, et al.The Journal of Infectious Diseases|September 18, 2013
Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric populationMaikel V W van der Velden, Richard Fritz, Eva Maria Pöllabauer, et al.Pageof 19